Completed PHASE2 INTERVENTIONAL 2-arm NCT01855594

Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain

Double Blind, Randomized Placebo-controlled Clinical Study Evaluating the Efficacy of Lithium Carbonate in the Treatment of Neuropathic Pain of Patients With Spinal Cord Injury

Sponsor: China Rehabilitation Research Center

Conditions Neuralgia Neuropathic Pain Spinal Cord Injuries

Interventions Lithium Carbonate Placebo

Updated 6 times since 2017 Last updated: Jan 26, 2016 Started: May 31, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neuralgia and Neuropathic Pain, this trial is completed. The trial is conducted by China Rehabilitation Research Center and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Rehabilitation Research Center
China Spinal Cord Injury Network
Second Affiliated Hospital of Xi'an Jiaotong University

Data source: China Spinal Cord Injury Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China
• Xi’an, China